NCT06624319View on ClinicalTrials.gov

Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2026

Conditions
Post Operative Pain
Interventions
DRUG

Dexmedetomidine as adjuvent to bupvacaine in tap block

The analgesic effect of Two different doses of dexmedetomidine as adjuvent to bupivacaine in tap block

Trial Locations (1)

Unknown

South egypt cancer institute,Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06624319 - Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block | Biotech Hunter | Biotech Hunter